We estimate that the CEO of ZEVRA THERAPEUTICS, INC. ($ZVRA), Neil F. McFarlane, received a compensation of $3,782,042 in 2025. This is a decrease of -41.59% from an estimated $5,355,059 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 20, 2026. Note that parsing errors may occur.
You can track $ZVRA on Quiver Quantitative's $ZVRA stock dashboard.
$ZVRA Stock Insider Trading Activity
$ZVRA Stock insiders have traded $ZVRA stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $ZVRA stock by insiders over the last 6 months:
- NEIL F. MCFARLANE (President and CEO) has made 0 purchases and 2 sales selling 105,625 shares for an estimated $978,610.
- JOSHUA SCHAFER (CCO) has made 0 purchases and 2 sales selling 13,875 shares for an estimated $126,300.
- TIMOTHY J. SANGIOVANNI (SVP, Finance & Corp Controller) has made 0 purchases and 2 sales selling 4,750 shares for an estimated $42,990.
- ADRIAN W QUARTEL (Chief Medical Officer) sold 4,533 shares for an estimated $40,035
- RAHSAAN THOMPSON (Chief Legal & Compliance) sold 4,080 shares for an estimated $36,009
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ZVRA Stock Hedge Fund Activity
We have seen 77 institutional investors add shares of $ZVRA Stock stock to their portfolio, and 80 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AIGH CAPITAL MANAGEMENT LLC removed 1,231,932 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $11,038,110
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 912,419 shares (-75.7%) from their portfolio in Q4 2025, for an estimated $8,175,274
- FMR LLC added 758,922 shares (+46.4%) to their portfolio in Q4 2025, for an estimated $6,799,941
- CITADEL ADVISORS LLC added 651,058 shares (+339.5%) to their portfolio in Q4 2025, for an estimated $5,833,479
- MORGAN STANLEY added 601,963 shares (+108.3%) to their portfolio in Q4 2025, for an estimated $5,393,588
- BLACKROCK, INC. added 469,897 shares (+11.6%) to their portfolio in Q4 2025, for an estimated $4,210,277
- ALGERT GLOBAL LLC removed 418,550 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,750,208
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ZVRA Stock Analyst Ratings
Wall Street analysts have issued reports on $ZVRA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 11/06/2025
To track analyst ratings and price targets for $ZVRA Stock, check out Quiver Quantitative's $ZVRA forecast page.
$ZVRA Stock Price Targets
Multiple analysts have issued price targets for $ZVRA recently. We have seen 3 analysts offer price targets for $ZVRA in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- Kambiz Yazdi from BTIG set a target price of $23.0 on 03/16/2026
- Kristen Kluska from Cantor Fitzgerald set a target price of $24.0 on 11/06/2025
- Sumant Kulkarni from Canaccord Genuity set a target price of $24.0 on 11/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
